These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 177335)

  • 41. [The computerized electroencephalogram in evaluating the action of vasoactive and eumetabolic drugs in chronic cerebrovascular disorders].
    Martucci N; Bocola V; Mearelli S; Agnoli A
    Riv Neurol; 1980; 50(2):73-97. PubMed ID: 6110238
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Use of complamin in nephrological practice].
    Mamikonian RS; Barsegian BA; Tumanian AM; Arutiunian VM; Basmadzhian NM
    Zh Eksp Klin Med; 1979; 19(4):62-7. PubMed ID: 506579
    [No Abstract]   [Full Text] [Related]  

  • 43. [Determinations of clinical variations and lipid metabolism in patients with chronic ischemia of the lower extremities by means of a pentosan sulfonic ester and xanthinol niacinate combination].
    González González M; Azcona Elizalde JM; Lorente Navarro MC; Duato Jane A
    Angiologia; 1979; 31(4):180-4. PubMed ID: 382919
    [No Abstract]   [Full Text] [Related]  

  • 44. The treatment of hardness of hearing with origin in the inner ear by means of Xavin.
    Révész G; Ribári O; Zelen B; Stanzel G
    Ther Hung; 1977; 25(2):64-8. PubMed ID: 898120
    [No Abstract]   [Full Text] [Related]  

  • 45. [Use of complamin in the complex intensive therapy of neurosurgical patients].
    Dukhin AL; Spasichenko PV; Spiridonova MV; Dunaevskaia SG; Iakovenko LN
    Vrach Delo; 1979 Mar; (3):17-21. PubMed ID: 452522
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of lipid-lowering treatment with xanthinol-nicotinate on the carbohydrate metabolism in mature-onset diabetics and non-diabetic patients with hyperlipoproteinemias (HLP)].
    Haacke H; Parwaresch MR; Rube O; Mäder C
    Verh Dtsch Ges Inn Med; 1978; (84):1157-60. PubMed ID: 741915
    [No Abstract]   [Full Text] [Related]  

  • 47. [Therapy of cerebrovascular insufficiency. A psychometric double-blind trial with a slow-release form of xantinol nicotinate (author's transl)].
    Brückner GW; Jansen W
    MMW Munch Med Wochenschr; 1979 Jun; 121(25):861-4. PubMed ID: 111104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of nicotinic acid and xanthinol nicotinate on human memory in different categories of age. A double blind study.
    Loriaux SM; Deijen JB; Orlebeke JF; De Swart JH
    Psychopharmacology (Berl); 1985; 87(4):390-5. PubMed ID: 3936095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of Xavin infusions in obliterating peripheral arterial disorders.
    Keller L; Landi A; Bársony J
    Ther Hung; 1975; 23(2):54-9. PubMed ID: 1188703
    [No Abstract]   [Full Text] [Related]  

  • 50. [Ergometric evaluation of treatment of ischemic heart disease with xavine].
    Zadionchenko VS; Vertkin AL; Martynov AI; Panchenkova LA; Troshina EV
    Sov Med; 1978 Jan; (1):68-73. PubMed ID: 635674
    [No Abstract]   [Full Text] [Related]  

  • 51. [Correction of the disordered rheological properties of the blood in patients with obstructive jaundice].
    Kuznetsov NA; Filimonov MI; Lopukhin SIu; Vasil'ev VE
    Khirurgiia (Mosk); 1983 Aug; (8):96-100. PubMed ID: 6632637
    [No Abstract]   [Full Text] [Related]  

  • 52. [Therapeutic effect of complamine in atherosclerosis and ischemic heart disease].
    Kalmykova VI; Aronchuk EK
    Sov Med; 1976 Jan; (1):113-8. PubMed ID: 1273633
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacological evaluation of xanthinol nicotinate (complamin).
    Galal E; Moustafa M; el-Gohary N; el-Mahdy SA; el-S Ali HI; Radwan AG
    J Egypt Med Assoc; 1976; 59(1-2):141-9. PubMed ID: 1032367
    [No Abstract]   [Full Text] [Related]  

  • 54. [Changes in the oxidative glucose brain metabolism under long-term xantinol-nicotinate medication (author's transl)].
    Quadbeck H; Lehmann E
    Arzneimittelforschung; 1978; 28(9):1531-2. PubMed ID: 582552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Assessment of the action of Sadamine Polfa and Mydocalm Richter preparations as based on photoplethysmography].
    Chwistecki K; Bochenek W; Lawiński M
    Pol Tyg Lek; 1975 Dec; 30(50):2093-6. PubMed ID: 1197101
    [No Abstract]   [Full Text] [Related]  

  • 56. [Use of complamin in complex rehabilitation treatment of post-stroke patients of older age groups].
    Man'kovskiĭ NB; Kostiuchenko VG; Tereshchenko LA
    Vrach Delo; 1978 Dec; (12):47-50. PubMed ID: 741723
    [No Abstract]   [Full Text] [Related]  

  • 57. [Xanthinic derivatives in the treatment of intermittent claudication syndrome in diabetic patients].
    Gómez Reyes D; Rojas Hidalgo E
    Rev Clin Esp; 1986 Jul; 179(3):162. PubMed ID: 3764000
    [No Abstract]   [Full Text] [Related]  

  • 58. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
    Spinella G; Majorana M
    Clin Ter; 1983 Mar; 104(5):375-81. PubMed ID: 6303677
    [No Abstract]   [Full Text] [Related]  

  • 59. [Use of xavin in vascular diseases of the lower extremities].
    Volgin EG
    Klin Med (Mosk); 1980 Oct; 58(10):46-50. PubMed ID: 7442096
    [No Abstract]   [Full Text] [Related]  

  • 60. [Microcirculation disorders and their correction in patients with acute pancreatitis].
    Petrushova LD
    Vrach Delo; 1983 Feb; (2):19-20. PubMed ID: 6845690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.